Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST001796)

(Analysis AN002917)

Metabolite	Structure	F1	F2	F3	F4
DG 34:3	ME417233	0.28	NA	2.22	0.14
Uvaricin	ME417435	NA	NA	1.66	0.00
2-Hydroxynonadecanoic acid	ME417183	0.43	1.04	2.43	0.57
3-Hydroxy-palmitic acid methyl ester	ME416945	0.42	1.09	2.12	0.74
6Z-Heneicosen-11-ol	ME417097	0.61	1.36	2.47	0.29
Methyl-hexadecenal	ME417101	0.57	1.36	2.16	0.49
PS P-36:1 or PS O-36:2	ME417397	0.56	0.37	2.20	0.90
CAR 17:0	ME417216	0.65	0.59	2.09	0.58
3-Ketosphingosine	ME417187	0.77	0.49	2.10	0.75
[FA (18:4)] 6Z_9Z_12Z_15Z-octadecatetraenoic acid	ME417084	0.62	0.55	2.17	0.79
Margaroylglycine	ME417288	0.82	0.45	2.37	0.58
[CPA(16:0)] 1-hexadecanoyl-sn-glycero-2_3-cyclic-phosphate	ME417119	0.65	0.58	2.40	0.63
Hexadecatrienoic acid	ME417254	0.62	0.58	2.29	0.71
4a-formyl-4ß-methyl-5a-cholesta-8-en-3ß-ol	ME416957	0.75	0.08	2.41	0.77
N-(9Z-octadecenoyl)-4E_6E-tetradecasphingadienine	ME417161	0.76	0.19	2.26	0.79
6-[3]-Ladderane-1-hexanol	ME417191	0.68	0.44	2.48	0.62
CAR 14:0	ME417210	0.70	0.35	2.56	0.60
Methyl acetyl ricinoleate	ME416970	0.72	0.36	2.52	0.60
6-[5]-ladderane-1-hexanol	ME417063	0.61	0.35	2.79	0.54
Octadecatrienoic acid	ME417310	0.60	0.35	2.61	0.65
FA methyl(17:3)	ME417077	0.65	0.34	2.65	0.59
MG 0:0/16:1(9Z)/0:0*	ME417291	0.60	0.36	2.68	0.60
PS 40:5	ME417384	0.79	0.41	1.96	0.85
stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside	ME417142	1.07	0.42	1.83	0.72
alpha-Tocopherol	ME417194	0.92	0.37	1.73	0.91
FA hydroxy(20:1)	ME417056	0.91	0.57	1.69	0.85
[SP (3:0)] sphinga-4E_8E_10E-trienine	ME417137	0.89	0.52	1.85	0.80
3-O-(6^-O-(13Z_16Z-docosadienoyl)-beta-D-glucopyranosyl)-stigmast-5-en-3beta-ol	ME417175	1.00	0.17	2.01	0.78
Antibiotic TA	ME416932	1.09	0.23	2.01	0.68
3-O-(6^-O-(13Z-docosenoyl)-beta-D-glucopyranosyl)-cholest-5-en-3beta-ol	ME417176	1.40	0.29	1.67	0.73
3-O-(6^-O-docosanoyl-beta-D-glucopyranosyl)-stigmast-5_22E-dien-3beta-ol	ME417172	1.17	0.21	1.82	0.75
LPE 22:0	ME417282	1.34	0.17	1.88	0.61
3-O-(6^-O-(13Z_16Z_19Z-docosatrienoyl)-beta-D-glucopyranosyl)-stigmast-5_22E-dien-3beta-ol	ME417174	0.84	NA	1.77	0.28
22alpha-Hydroxy-campest-4-en-3-one	ME416996	0.93	NA	1.68	0.52
3-O-(beta-D-glucopyranosyl)-campest-5-en-3beta-ol	ME417170	0.85	NA	1.72	0.47
4a-carboxy-4ß-methyl-5a-cholesta-8-en-3ß-ol	ME416934	1.11	0.07	1.50	1.03
3-O-(6^-O-(13Z_16Z_19Z-docosatrienoyl)-beta-D-glucopyranosyl)-cholest-5-en-3beta-ol	ME417178	0.98	NA	1.31	0.81
TG(20:5/22:6/20:5)(D5)	ME416929	0.77	NA	1.55	0.81
N-Stearoyl glycine	ME417307	0.23	0.15	3.98	0.21
3-O-(6^-O-(13Z_16Z_19Z-docosatrienoyl)-beta-D-glucopyranosyl)-stigmast-5-en-3beta-ol	ME417169	0.27	NA	4.17	0.16
[ST hydroxy(3:2/3:0/3:0)] (5Z_7E)-(1R_2R_3R)-3-(hydroxy-propyl)-19-nor-9_10-seco-5_7-cholestadien-1_3_25-triol	ME417144	0.22	0.10	4.10	0.17
FA methyl(18:2)	ME417031	0.03	0.04	4.64	0.02
Androsterone	ME417197	0.04	0.03	4.34	0.05
[ST (2:0)] androstan-3beta_17beta-diol	ME417141	0.10	0.02	4.48	0.07
CAR 12:0	ME417209	0.05	0.06	3.35	0.06
N-Palmitoyl threonine	ME417306	0.03	0.03	3.19	0.03
3-O-(6^-O-docosanoyl-beta-D-glucopyranosyl)-stigmast-5-en-3beta-ol	ME417171	0.75	0.02	2.77	0.59
4a-hydroxymethyl-4ß-methyl-5a-cholesta-8_24-dien-3ß-ol	ME416939	0.67	0.07	2.93	0.53
Arachidonoyl Serotonin	ME417007	0.54	0.21	3.00	0.40
FA hydroxy(18:1)	ME417022	0.41	0.37	3.15	0.46
5beta-Pregnane-3_20-dione	ME417150	0.45	0.28	2.97	0.57
PS 38:2	ME417380	0.42	0.31	2.99	0.57
3-O-(6^-O-docosanoyl-beta-D-glucopyranosyl)-cholest-5-en-3beta-ol	ME417173	0.51	0.02	3.41	0.39
N-(3-(15-methyl-hexadecanoyloxy)-13-methyl-tetradecanoyl)-L-serine	ME417070	0.52	0.06	3.27	0.45
5beta-Estrane-3alpha_17beta-diol	ME416944	0.29	0.26	3.48	0.31
(+/-)-5-[(tert-Butylamino)-2^-hydroxypropoxy]-1_2_3_4-tetrahydro-1- naphthol	ME416951	0.25	0.46	3.51	0.34
PA P-37:0 or PA O-37:1	ME417317	0.24	NA	1.05	1.44
Arachidonoyl-EA	ME417199	0.70	0.39	1.38	1.26
PS P-36:2 or PS O-36:3	ME417398	0.48	0.36	1.59	1.31
[GL (18:0)] 1-octadecanoyl-rac-glycerol	ME417103	1.96	0.72	0.64	0.64
3-O-Sulfogalactosylceramide(d18	ME417128	1.83	0.59	0.41	0.92
Spisulosine	ME417417	1.63	0.54	0.71	0.78
6Z_9Z-Heneicosadien-11R-ol	ME417012	1.86	0.46	0.63	0.83
CTAB	ME416946	1.92	0.56	0.60	0.76
[FA hydroxy_methoxy(18:0)] 12_13-dihydroxy-11-methoxy-9-octadecenoic acid	ME417033	1.76	0.48	0.59	0.92
3-Hydroxy-5_ 8-tetradecadiencarnitine	ME416941	1.70	0.35	0.65	0.97
sn-1_2-Di(2-propylpentanoyl)glycerol	ME416948	1.77	0.37	0.64	0.92
Mycolipanolic acid (C27)	ME417075	2.13	0.14	0.28	0.97
PC 42:10	ME417337	2.19	0.12	0.38	0.89
Erucicoyl-EA	ME417247	1.95	0.38	0.56	0.61
6Z_9Z-Heneicosadien-11S-ol	ME417038	2.27	0.33	0.49	0.67
Tricosene	ME417027	2.19	0.44	0.52	0.67
1-O-Octadec-9-enyl glycerol	ME416930	0.65	0.67	0.81	1.50
FA hydroxy(20:3)	ME417074	0.55	0.73	0.57	1.68
[FA (13:2)] 3E_5E-tridecadienoic acid	ME417055	0.92	0.62	0.74	1.37
N-Undecanoylglycine	ME417308	0.90	0.64	0.66	1.42
PS O-18:0	ME417386	0.94	0.61	0.66	1.40
1-tetradecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine	ME417122	0.91	0.54	0.92	1.31
FA methyl (8:1)	ME417057	1.00	0.59	0.92	1.23
Tridecadienoic acid	ME417429	0.98	0.77	0.78	1.24
MG 16:1(9Z)/0:0/0:0*	ME417294	0.92	0.72	0.94	1.21
N-propyl-16_16-dimethyl-5Z_8Z_11Z_14Z-docosatetraenoyl amine	ME417050	0.81	0.76	0.86	1.32
PS 38:0	ME417378	0.81	0.88	0.47	1.49
CAR 16:0	ME417212	0.97	0.90	0.54	1.32
N-(8Z_11Z_14Z-eicosatrienoyl)-ethanolamine	ME417082	1.08	0.93	0.59	1.21
[FA trimethyl(13:0)] 4_8_12-trimethyl-tridecanoic acid	ME417039	1.47	0.96	1.11	0.68
[FA hydroxy(20:0)] dihydroxy-eicosanoic acid	ME417098	1.02	1.14	0.98	0.94
[ST hydroxy_methyl_ethyl(2:0)] (5Z_7E)-(1S_3R)-22-[3-(1-hydroxy-1-methylethyl)phenyl]-23_24-dinor-9_10-seco-5_7_10(19)-cholatriene-1_3-diol	ME417154	1.06	1.13	0.97	0.92
DG 42:9	ME417238	0.89	1.20	1.10	0.93
FA (14:1) nonanol	ME417064	0.85	1.20	1.08	0.98
Buddledin A	ME417205	0.94	1.25	1.09	0.88
Prosafrinine	ME417373	0.98	1.19	1.07	0.89
Oleoyl-EA	ME417312	0.94	1.06	1.26	0.87
[SP hydroxy_hydroxy_methyl(10:2/2:0)] 6R-(8-hydroxydecyl)-2R-(hydroxymethyl)-piperidin-3R-ol	ME417130	0.80	1.06	1.29	0.96
4-8dimethylnonanoylcarnitine	ME417004	0.90	1.03	1.06	1.02
PA 39:0	ME417315	0.96	1.05	1.00	1.00
Geranylgeraniol	ME416988	0.89	1.03	1.17	0.97
Anacardic acid	ME417196	0.91	1.06	1.13	0.96
Tributyl phosphate	ME417427	0.91	1.08	1.10	0.97
20:2(5Z_9Z)(11Me_15Me_19Me)	ME417125	0.96	1.01	1.15	0.94
Pentadecanoyl-EA	ME417356	1.01	0.96	1.13	0.93
3_7_11-Trimethyl-6E_10-dodecadien-1-ol	ME417035	0.83	0.97	1.12	1.06
FA oxo(17:0)	ME417095	0.92	0.88	1.04	1.09
PS P-39:0 or PS O-39:1	ME417400	1.19	0.95	1.03	0.86
Stylisterol B	ME417420	1.13	0.94	1.05	0.91
[FA hydroxy(18:1)] 9_10-dihydroxy-12Z-octadecenoic acid	ME417042	1.15	0.94	1.23	0.79
[SP dimethyl_amino(18:0/2:0)] 2S-dimethylaminooctadecane-1_3R-diol	ME417131	1.21	0.83	1.18	0.82
PG O-32:0	ME417360	1.14	0.65	1.19	0.94
PI 40:8	ME417367	1.07	0.65	0.96	1.12
Penaresidin A	ME417354	1.05	0.64	1.05	1.08
[FA (18:3)] 9_12_15-octadecatrienal	ME417090	1.05	0.67	1.08	1.06
PA 17:0/0:0*	ME417313	1.04	0.65	1.09	1.07
Xeniasterol-b	ME417153	0.96	0.84	1.14	1.02
Androstane-3_17-diol dipropionate	ME416927	1.03	0.78	1.05	1.04
Heneicosadienone	ME417067	1.07	0.81	1.12	0.96
1-eicosanoyl-(1-cyano-2-methylprop-2-en-1-ol)	ME417028	1.29	0.92	0.84	0.92
[FA (15:0)] 14-methy-pentadecanoic acid	ME417100	1.25	0.81	0.85	0.99
FA oxo(20:2)	ME417062	1.21	0.86	0.92	0.96
bis(2-Ethylhexyl)phthalic acid	ME417204	0.96	0.85	0.91	1.14
Lacinilene C 7-methyl ether	ME417256	1.02	0.84	0.89	1.12
LPE 15:0	ME417278	1.02	0.83	0.90	1.12
[FA hydroxy(20:0)] 11_12-dihydroxy-eicosanoic acid	ME417080	1.12	0.80	0.95	1.03
[SP hydroxy_methyl_hydroxy_methyl(16:2)] azetidinol	ME417136	1.15	0.78	0.97	1.00
[FA (18:2)] 3Z_13Z-octadecadien-1-ol	ME417089	1.10	0.85	0.86	1.07
MG 18:0/0:0/0:0*	ME417295	1.09	0.86	0.84	1.08
Diethylhexyl adipate	ME417241	1.07	0.93	0.96	1.00
Triphenyl phosphate	ME417432	1.05	0.90	0.92	1.05
Stearamide	ME417418	1.11	0.87	0.93	1.02
Tomatidine	ME417424	1.09	0.86	0.93	1.04
Decanamide	ME417229	1.18	1.05	0.84	0.94
MG 22:0/0:0/0:0*	ME417297	1.12	1.00	0.85	1.00
N-(4Z_7Z_10Z_13Z_16Z_19Z-docosahexaenoyl)-ethanolamine	ME417102	1.16	0.97	0.85	0.96
Sphinganine(d17:0)Ê	ME416989	1.07	1.10	0.79	1.02
Tuberculostearic acid	ME417433	1.00	1.11	0.82	1.06
3-Hydroxyhexdecanedioyl-CoA	ME416992	1.00	0.93	0.89	1.09
Oleic acid methyl ester	ME416968	1.06	0.94	0.84	1.07
Hexadecenal	ME416990	1.04	1.01	0.84	1.05
MG 0:0/16:0/0:0	ME417290	1.04	1.00	0.88	1.04
Minabeolide-2	ME417139	1.00	0.81	1.26	0.54
[FA methyl(18:2)] methyl 12_13-epoxy-9_15-octadecadienoate	ME417061	0.80	0.91	1.54	0.87
trans-2-Tetradecenoylcarnitine	ME417425	0.87	0.99	1.60	0.75
Undecanoylcholine	ME417434	0.77	1.05	1.60	0.80
3-Dehydroteasterone	ME417186	0.98	0.83	1.47	0.82
1-dimethylamino-9S_11R_15S-trihydroxy-5Z_13E-prostadiene	ME417087	0.93	0.88	1.36	0.89
FA oxo(21:0)	ME417092	0.99	0.83	1.29	0.91
beta-Tocotrienol	ME416967	1.36	0.54	1.22	0.81
Cer 33:0;O2	ME417223	1.37	0.56	1.23	0.79
Cer 31:0;O2	ME417222	1.24	0.69	1.25	0.81
[FA (18:2)] 9Z_11E-octadecadienoic acid	ME417036	1.34	0.68	1.14	0.81
FA trihydroxy(18:1)	ME417081	1.18	0.35	1.39	0.93
LPE 24:0	ME417285	1.10	0.32	1.11	0.95
PE 36:2	ME417349	1.27	0.36	1.10	1.03
LPE 20:2	ME417281	1.30	0.43	1.15	0.95
PS 40:4	ME417383	1.26	0.49	1.10	0.98
LPE 22:1	ME417283	1.18	0.41	1.22	1.00
N-(9Z_12Z-octadecadienoyl)-ethanolamine	ME417088	1.22	0.42	1.22	0.97
LPC 17:0	ME417264	1.29	0.30	1.20	0.98
TG(20:2/18:3/20:2)(D5)	ME416964	1.23	0.29	1.28	0.98
CAR 18:2	ME417219	1.00	0.39	1.55	0.93
trans-Hexadec-2-enoylcarnitine	ME416972	1.01	0.48	1.54	0.91
[FA hydroxy(20:4)] eicosatetraenoyl amine	ME417069	1.07	0.51	1.22	1.04
LPE 18:0	ME417280	1.04	0.48	1.26	1.04
[PR] 13-cis-retinol	ME417127	1.04	0.48	1.28	1.03
GlcCer 15:1;O2/22:0	ME417250	1.00	0.50	1.25	1.08
[SP amino(18:0/2:0)] 2S-aminooctadecane-1_3R-diol	ME417134	1.02	0.46	1.26	1.07
9_12-Hexadecadienoylcarnitine	ME416961	1.10	0.49	1.28	0.99
LPC P-16:0 or LPC O-16:1	ME417276	1.05	0.50	1.34	0.98
3 beta_7 alpha-Dihydroxy-5-cholestenoate	ME417006	0.98	0.56	1.39	0.98
Latia luciferin	ME416981	0.87	0.54	1.41	1.05
MG 20:4	ME417296	1.38	0.48	1.11	0.89
4-Dodecylphenol	ME417189	1.41	0.45	1.02	0.93
[SP methyl(2:0)] 9-methyl-sphinga-4E_8E-dienine	ME417133	1.40	0.46	1.03	0.93
FA (14:1)nonanoic acid	ME417066	1.36	0.56	0.97	0.95
10Z-Tricosene	ME417052	1.25	0.56	1.03	0.99
Pentacosene	ME417059	1.25	0.56	1.01	1.00
Tridecenoic acid	ME417430	1.29	0.62	0.96	0.97
8E-Heneicosene	ME417085	1.20	0.66	0.95	1.03
PC 18:2	ME417321	1.24	0.62	0.96	1.02
Dodecadienoic acid	ME417244	1.40	0.62	0.88	0.94
Lignoceric acid	ME417258	1.45	0.58	0.75	1.00
Cerotic acid	ME417224	1.43	0.63	0.80	0.96
[FA hydroxy(18:1/2:0)] 8-hydroxy-13Z-octadecene-9_11-diynoic acid	ME417021	1.44	0.61	0.80	0.96
PC 22:1	ME417322	1.27	0.52	0.93	1.05
Heneicosenoic acid	ME417252	1.33	0.48	0.94	1.02
Myxalamid S	ME416995	1.31	0.44	0.91	1.07
Retinal	ME417404	1.38	0.48	0.89	1.01
[SP methyl(16:0)] 15-methyl-hexadecasphing-4E-enine	ME417132	1.43	0.47	0.89	0.98
Centarol	ME417221	1.37	0.50	0.84	1.04
[ST hydrox] 3beta-hydroxypregn-5-ene-20-one	ME417145	1.42	0.46	0.79	1.05
Fucoxanthin	ME417248	1.29	0.60	0.67	1.15
PE 34:1	ME417348	1.29	0.63	0.68	1.13
PC 26:0	ME417324	1.30	0.64	0.73	1.09
PG 33:4	ME417358	1.32	0.65	0.68	1.10
6Z_9Z-Eicosadien-11-ol	ME417015	1.37	0.61	0.77	1.04
Dihydroceramide	ME417135	1.30	0.58	0.77	1.09
N-(2-hydroxytridecanoyl)-4_8-sphingadienine	ME416993	1.22	0.62	0.60	1.18
N-morpholine-5Z_8Z_11Z_14Z-eicosatetraenoyl amine	ME417071	1.27	0.67	0.60	1.18
17-Propyl-5alpha-androst-2-en-17beta-ol	ME416953	1.16	0.63	0.64	1.25
Octadecadienal	ME417078	1.18	0.64	0.67	1.22
[PC(22:6)] 1-(4Z_7Z_10Z_13Z_16Z_19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine	ME417120	1.19	0.55	0.65	1.26
LPC 16:0	ME417262	1.25	0.54	0.67	1.21
PS(O-18:0/20:5(5Z_8Z_11Z_14Z_17Z))	ME417121	1.23	0.56	0.68	1.21
[FA (16:2)] N-hexadecyl-ethanolamine	ME417076	1.12	0.71	0.83	1.13
PC 18:1	ME417320	1.13	0.62	0.81	1.18
FA hydroxy(12:1)	ME417060	1.17	0.65	0.93	1.10
Himbacine	ME416954	1.23	0.60	0.86	1.09
[FA oxo(22:0)] 10-oxo-docosanoic acid	ME417079	1.13	0.51	0.95	1.15
[FA hydroxy(21:0)] 14-hydroxy-heneicosanoic acid	ME417049	1.24	0.52	0.83	1.13
alpha-Linolenoyl-EA	ME417192	1.19	0.47	0.85	1.18
LPC 20:1	ME417268	1.22	0.47	0.85	1.15
LPE 16:1	ME417279	1.12	0.45	0.78	1.28
Dehydrophytosphingosine	ME417230	1.15	0.49	0.80	1.23
DG 18:0/24:1(15Z)/0:0*	ME417231	1.12	0.55	0.82	1.21
[PC(11:1/11:1)] 1-(10E-undecenoyl)-2-(10E-undecenoyl)-sn-glycero-3-phosphocholine	ME417116	1.02	0.36	0.74	1.38
PS P-38:1 or PS O-38:2	ME417399	0.97	0.32	1.07	1.27
2S_3R-Didecanoyl-docosane-2_3-diol	ME417032	1.24	0.19	0.96	1.20
SM 33:2;O2	ME417413	1.12	0.28	0.97	1.24
[ST] (5Z_7E)-9_10-seco-5_7_10(19)-cholestatriene	ME417152	1.10	0.21	0.99	1.27
alpha-Tocotrienol	ME417195	1.73	0.35	1.39	0.46
2-Hydroxylauroylcarnitine	ME416938	1.81	0.28	1.09	0.68
FA oxo(10:0)	ME417030	1.58	0.48	1.01	0.80
[ST (2:0)] 5beta-Cholane-3alpha_24-diol	ME417140	1.67	0.46	0.90	0.89
9-Hexadecenoylcholine	ME416936	1.43	0.23	1.06	0.99
N-(11Z_14Z-eicosadienoyl)-ethanolamine	ME417009	1.47	0.25	1.12	0.92
PI 39:4	ME417366	1.48	0.26	1.16	0.88
[FA (18:3)] octadecatrienal	ME417024	1.49	0.41	1.18	0.80
[PS(10:0)] 1_2-didecanoyl-sn-glycero-3-phosphoserine	ME417114	1.63	0.32	1.09	0.79
[ST (3:0)] cholest-5Z_7Z_24-trien-3beta-ol	ME417138	0.82	0.09	0.21	1.97
Cholesta-5_7-dien-3beta-ol	ME417002	0.86	0.07	0.70	1.67
Noladin Ether	ME417104	0.77	0.30	0.73	1.58
[FA hydroxy(23:0)] 2-hydroxy-tricosanoic acid	ME417054	1.35	0.87	0.21	1.26
Tricosenoic acid	ME417428	1.29	0.89	0.25	1.27
DG 39:8	ME417236	1.26	0.94	0.38	1.16
[ST hydroxy_methyl_ethyl(2:0)] (5Z_7E)-(1S_3R)-18-[m-(1-hydroxy-1-methylethyl)-benzyloxy]-23_24-dinor-9_10-seco-5_7_10(19)-cholatriene-1_3-diol	ME417147	1.25	0.85	0.54	1.15
PA 40:3	ME417316	1.58	0.54	0.18	1.25
[PC(18:3)]	ME417118	1.32	0.60	0.38	1.30
DG 37:5	ME417235	1.39	0.63	0.32	1.27
sarmentogenin	ME417149	1.40	0.60	0.32	1.28
LPC P-18:1 or LPC O-18:2	ME417277	1.14	0.43	0.57	1.39
MG 0:0/22:0/0:0*	ME417292	1.13	0.42	0.66	1.35
LPC 16:1(9Z)*	ME417263	1.16	0.49	0.62	1.32
LPC 22:5	ME417273	1.09	0.51	0.62	1.36
[FA hydroxy_ethyl(20:4/20:4)] N-(1_1-dimethy-2-hydroxy-ethyl)-5Z_8Z_11Z_14Z-eicosatetraenoyl amine	ME417068	1.24	0.53	0.48	1.33
GlcCer 18:0;O2/18:0	ME417251	1.22	0.47	0.47	1.37
DG(18:0e/2:0/0:0)	ME417107	1.27	0.57	0.51	1.27
LPC 20:4	ME417271	1.22	0.54	0.57	1.28
Heterodendrin	ME417253	1.17	0.73	0.54	1.26
MG(0:0/20:2(11Z_14Z)/0:0)	ME417109	1.06	0.72	0.58	1.31
LPC 18:1	ME417266	1.26	0.74	0.36	1.29
LPC 14:0	ME417261	1.15	0.72	0.39	1.36
SM 32:2;O2	ME417411	1.12	0.66	0.43	1.30
1-(O-alpha-D-glucopyranosyl)-(3R_29S_31R)-dotriacontanetriol	ME417047	1.08	0.18	0.47	1.60
Docosanamide	ME417243	1.06	0.31	0.47	1.56
CAR 16:0;OH	ME417213	1.00	0.50	0.44	1.53
PS O-20:0/0:0*	ME417387	1.08	0.53	0.48	1.44
[FA hydroxy(15:0)] 3_12-dihydroxy-pentadecanoic acid	ME417020	0.97	0.51	0.33	1.62
PS(O-16:0/22:2(13Z_16Z))	ME417117	1.05	0.50	0.28	1.59
PC 36:6	ME417335	1.15	0.47	0.26	1.55
PC 42:11	ME417338	1.10	0.46	0.32	1.45
PC 32:2	ME417330	1.15	0.54	0.33	1.47
PC 40:9	ME417336	1.18	0.48	0.32	1.48
Cyclopamine	ME417228	1.17	0.02	0.40	1.36
[ST (2:0)] 24-Nor-5beta-chol-22-ene-3alpha_6alpha-diol	ME417143	1.25	0.02	0.34	1.62
SM 33:1;O2	ME417412	1.40	0.14	0.61	1.31
LPC 24:0	ME417274	1.32	0.26	0.52	1.36
SM 34:2;O2	ME417415	1.28	0.29	0.53	1.38
3-O-(6^-O-(11Z-eicosenoyl)-beta-D-glucopyranosyl)-cholest-5-en-3beta-ol	ME417177	1.34	0.19	0.55	1.30
SM 18:1;O2/16:0	ME417409	1.32	0.23	0.57	1.34
N-(2-hydroxy-eicosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine	ME417168	1.20	0.33	0.48	1.44
N-(eicosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine	ME417165	1.14	0.39	0.48	1.46
PE O-16:0/13:0	ME417351	1.24	0.18	0.53	1.45
4a-carboxy-5a-cholesta-8-en-3ß-ol	ME416931	1.18	0.24	0.44	1.43
4a-formyl-5a-cholesta-8-en-3ß-ol	ME416984	1.28	0.25	0.43	1.45
PA 22:0/0:0*	ME417314	1.34	0.34	0.19	1.38
PS 30:0	ME417374	1.48	0.36	0.22	1.38
PC 34:4	ME417334	1.30	0.46	0.27	1.43
PC 34:3	ME417333	1.34	0.38	0.30	1.42
PE 36:3	ME417350	1.31	0.39	0.30	1.44
CAR 20:0	ME417220	1.28	0.48	0.37	1.38
D-Glucosyldihydrosphingosine	ME417240	1.38	0.43	0.34	1.35
SM 18:0;O2/16:0	ME417407	1.47	0.28	0.37	1.33
SM 34:1;O2	ME417414	1.42	0.26	0.38	1.37
PC P-22:3 or PC O-22:4	ME417343	1.37	0.30	0.28	1.45
PS 36:0	ME417377	1.39	0.33	0.28	1.42
[FA hydroxy(3:2/20:4)] N-(3-hydroxy-propyl)-5Z_8Z_11Z_14Z-eicosatetraenoyl amine	ME417023	1.36	0.33	0.40	1.38
14Z-Tricosene-10-one	ME417016	1.37	0.28	0.34	1.42
PS 34:0	ME417376	1.34	0.25	0.38	1.44
SM 32:1;O2	ME417410	1.32	0.28	0.38	1.43
anhydroretinol	ME416985	1.21	0.12	0.22	1.45
PC 30:0	ME417326	1.26	0.33	0.15	1.59
PS O-34:0	ME417388	1.17	0.24	0.24	1.53
PE 32:0	ME417347	1.24	0.30	0.29	1.54
Sphinganine	ME417416	1.24	0.37	0.23	1.54
DG(1_3-19:0)(D5)	ME416971	1.27	NA	0.70	0.94
PI 37:4	ME417364	1.61	0.11	0.80	1.06
3beta-(1-Pyrrolidinyl)-5alpha-pregnane-11_20-dione	ME416935	1.41	0.03	0.69	1.30
DG(1_3-20:2)(D5)	ME416974	1.41	0.02	0.67	1.17
LPC 20:0	ME417267	1.45	0.21	0.92	1.07
DG(1_3-20:4)(D5)	ME416975	1.34	0.04	0.89	1.24
PE O-28:0	ME417352	1.33	0.16	0.78	1.13
[FA (25:0)] tricosane-1_2-diol	ME417041	1.42	0.15	0.79	1.19
[FA methyl(21:0/2:0)] 15-methylheneicosane-1_2-diol	ME417058	1.35	0.14	0.87	1.19
MG O-16:0	ME417298	1.74	0.25	0.56	1.04
Pregnanediol	ME417371	1.63	0.29	0.51	1.13
PS P-32:1 or PS O-32:2	ME417392	1.65	0.27	0.50	1.13
Dimethisterone	ME417242	1.70	0.26	0.28	1.23
MG O-18:0	ME417299	1.75	0.19	0.41	1.15
PS P-40:3 or PS O-40:4	ME417401	1.22	0.26	0.74	1.31
N-(2-hydroxy-docosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine	ME417164	1.32	0.29	0.66	1.27
Hentriacontane-14_16-dione	ME416994	1.23	0.36	0.69	1.29
LPC 20:2	ME417269	1.26	0.35	0.67	1.28
LPC 24:1(15Z)*	ME417275	1.31	0.42	0.79	1.15
N-(15Z-tetracosenoyl)-tetradecasphing-4-enine-1-phosphoethanolamine	ME417166	1.32	0.43	0.74	1.17
PE P-16:0/13:0 or PE O-16:1/13:0	ME417353	1.31	0.30	0.81	1.19
PI 38:7	ME417365	1.35	0.32	0.75	1.18
TG 39:0	ME417422	1.49	0.36	0.69	1.10
26:6(8Z_11Z_14Z_17Z_20Z_23Z)	ME417025	1.56	0.38	0.73	1.03
11-cis-Retinol	ME417180	1.60	0.34	0.64	1.06
12-[3]-ladderane-dodecanoic acid	ME417014	1.58	0.36	0.65	1.06
R-Dysidazirine	ME417403	1.51	0.49	0.66	1.05
Thymyl acetate	ME416980	1.43	0.55	0.63	1.10
1-(14-methyl-pentadecanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol	ME417108	1.44	0.20	0.49	1.32
N-(2-hydroxy-docosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine	ME417163	1.43	0.20	0.44	1.36
PC O-24:0	ME417341	1.43	0.19	0.46	1.35
PI 36:0	ME417363	1.50	0.20	0.48	1.28
TG(14:0/16:1/14:0)(D5)	ME416942	1.49	0.14	0.51	1.30
Aristolochene	ME416998	1.55	0.29	0.43	1.24
PS 32:1	ME417375	1.45	0.32	0.49	1.26
[ST dimethyl_methy] 4alpha_14alpha-dimethyl-24-methylene-cholest-8-en-3beta-ol	ME417148	1.47	0.28	0.50	1.25
12beta-hydroxy-24-norcholesta-1_4_22E-trien-3-one	ME417151	1.60	0.11	0.56	1.21
DG 40:0	ME417237	1.54	0.14	0.54	1.25
5-(Heptadec-12-enyl)resorcinol	ME416933	1.45	0.24	0.61	1.22
N-(2-hydroxy-hexacosanoyl)-tetradecasphing-4-enine	ME417162	1.48	0.23	0.57	1.17
4_8-Dimethyl-1_3E_7-nonatriene	ME417073	1.52	0.31	0.55	1.18
7_10_13_16-Docosatetraenoylethanolamine	ME416937	1.53	0.27	0.62	1.15
Behenoylglycine	ME417202	1.47	0.42	0.32	1.30
N-(2-hydroxy-13Z-docosenoyl)-tetradecasphing-4-enine	ME417159	1.51	0.36	0.34	1.29
[PI(18:1)] 1-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1^-myo-inositol)	ME417115	1.48	0.40	0.40	1.26
PS P-29:0 or PS O-29:1	ME417390	1.55	0.41	0.42	1.19
Rishitin	ME417406	1.51	0.44	0.40	1.22
3-O-(6^-O-(7Z-hexadecenoyl)-beta-D-glucopyranosyl)-cholest-5-en-3beta-ol	ME417179	1.40	0.37	0.46	1.30
LPC 22:0	ME417272	1.35	0.33	0.50	1.32
Oblongolide	ME417309	1.41	0.37	0.52	1.25
PI 40:9	ME417368	1.37	0.38	0.56	1.26
PS P-28:0 or PS O-28:1	ME417389	1.37	0.40	0.55	1.25
LPC 18:0	ME417265	1.38	0.41	0.49	1.27
LPC 20:3	ME417270	1.37	0.46	0.53	1.24
Veatchine	ME416999	1.35	0.45	0.50	1.27
Zwittergent 3-14	ME416978	1.29	0.35	0.57	1.32
LPE 22:4	ME417284	1.26	0.46	0.59	1.28
PC O-20:0	ME417340	1.26	0.43	0.61	1.28
beta-Estradiol	ME417203	1.51	0.50	0.52	1.13
PS P-31:1 or PS O-31:2	ME417391	1.47	0.42	0.56	1.16
Bakkenolide A	ME417201	1.48	0.43	0.54	1.16
Melibiose	ME417289	1.47	0.43	0.54	1.17
[FA methyl(18:0)] 9_10-methylene-9-octadecenoic acid	ME417045	1.45	0.48	0.51	1.18
alpha-Curcumene	ME416965	1.45	0.41	0.53	1.20
3-tert-Butyl-5-methylcatechol	ME417188	1.44	0.44	0.53	1.20
7Z-Tricosen-11-one	ME417026	1.44	0.45	0.52	1.19
Capsidiol	ME416997	1.45	0.37	0.54	1.21
14^-apo-beta-Carotenal	ME417181	1.54	0.38	0.49	1.17
Retinol	ME417405	1.50	0.36	0.49	1.20
3alpha-Hydroxy-5beta-pregnane-20-one	ME417185	1.49	0.38	0.50	1.20
all-trans-13_14-Dihydroretinol	ME417156	1.50	0.37	0.50	1.20
alpha-Linoleoylcholine	ME417193	1.37	0.37	0.64	1.21
MG(0:0/22:2(13Z_16Z)/0:0)	ME417112	1.41	0.36	0.61	1.21
FA oxo(19:0)	ME417029	1.39	0.39	0.67	1.17
PC(16:0/9:0(CHO))	ME417113	1.45	0.39	0.65	1.15
24:3(15Z_18Z_21Z)	ME417048	1.32	0.57	0.62	1.17
Nebrosteroid M	ME417302	1.34	0.52	0.68	1.15
PG 31:0	ME417357	1.36	0.52	0.62	1.16
3_5_7-Trimethyl-2E_4E_6E_8E-decatetraene	ME417053	1.40	0.43	0.60	1.19
9_12_15-Octadecatrien-1-ol	ME417065	1.41	0.48	0.64	1.14
Falcarindiol	ME416977	1.40	0.46	0.63	1.16
Margaroyl-EA	ME417287	1.39	0.47	0.61	1.17
4-Hexyloxyphenol	ME416952	1.37	0.48	0.58	1.20
Nonadecylic acid	ME417305	1.39	0.52	0.54	1.19
TG(10:0/10:0/10:0)[iso]	ME417106	1.39	0.17	0.11	1.58
DG 24:0	ME417232	1.37	0.06	0.02	1.56
[FA oxo(15:0)] 4-oxo-pentadecanoic acid	ME417046	1.40	0.10	0.06	1.64
Ergosta-5_7_22_24(28)-tetraen-3beta-ol	ME417003	1.56	0.08	0.15	1.48
N-(2-hydroxydocosanoyl)-sphinganine	ME417158	1.49	0.10	0.15	1.52
GlcCer 14:1;O2(4E)/20:0;O	ME417249	1.55	0.24	0.20	1.39
PS P-42:5 or PS O-42:6	ME417402	1.53	0.20	0.17	1.44
3-Keto-4-methylzymosterol	ME417005	1.66	0.10	0.20	1.37
N-(2-hydroxyeicosanoyl)-sphinganine	ME417160	1.60	0.16	0.19	1.39
3_7_11_15_19-Pentamethyleicosa-2E_6E_10E_14E_18-pentaen-1-ol	ME417019	0.86	0.17	NA	1.45
PE 29:0	ME417345	0.94	0.43	0.00	1.43
PS P-33:0 or PS O-33:1	ME417393	0.99	0.23	NA	1.33
PS P-35:0 or PS O-35:1	ME417394	0.98	0.30	NA	1.31
PE 28:0	ME417344	1.14	0.25	NA	1.22
PE 30:2	ME417346	1.08	0.33	NA	1.23
[FA oxo(15:0)] 11-oxo-pentadecanoic acid	ME417043	1.16	0.14	0.08	1.78
PS P-36:0 or PS O-36:1	ME417396	1.18	0.37	0.02	1.70
PC 28:0	ME417325	1.25	0.37	0.01	1.66
PS O-16:0/22:1(11Z)*	ME417385	1.26	0.36	0.02	1.65
SM 18:1;O2/12:0	ME417408	1.27	0.57	0.04	1.54
PC 32:4	ME417332	1.02	0.42	0.08	1.63
PC 30:1	ME417327	1.13	0.56	0.04	1.65
CAR 18:0	ME417217	1.14	0.48	0.16	1.60
PC 32:3	ME417331	1.15	0.50	0.14	1.60
FA oxo(14:1) cyclopentanebutanoic acid	ME417093	0.53	0.94	0.17	1.83
N-(nonadecanoyl)-4E_6E-tetradecasphingadienine-1-phosphoethanolamine	ME417167	1.12	0.76	NA	1.04
LPC 12:0	ME417260	0.98	0.74	NA	1.13
PC 30:3	ME417329	0.91	0.68	NA	1.21
PC 24:0	ME417323	0.83	0.89	0.01	1.45
PG 36:1	ME417359	0.86	0.87	0.06	1.42
PC 30:2	ME417328	1.14	0.71	0.04	1.57
PS P-35:1 or PS O-35:2	ME417395	1.06	0.79	0.15	1.54
8Z-Heptadecene	ME417037	1.50	NA	0.75	NA
Convallagenin A	ME417227	1.23	NA	1.18	0.06
MG(0:0/22:4(7Z_10Z_13Z_16Z)/0:0)	ME417110	1.36	NA	1.12	0.17
Jurubine	ME417155	2.78	NA	0.56	NA
7Z-Octadecene	ME417018	2.82	0.21	0.22	0.12
Tridemorph	ME417431	2.94	0.31	0.37	0.27
3-Dehydro-2-deoxyecdysone	ME417000	2.21	NA	0.93	0.05
[FA (24:0)] tetracosanal	ME417034	2.18	0.19	0.36	0.17
[SP amino_dimethyl(18:0)] 2-amino-14_16-dimethyloctadecan-3-ol	ME417129	1.96	0.18	0.30	0.09
di-n-Undecylamine	ME416928	2.47	0.25	0.33	0.39
Tetrapentylammonium	ME417421	2.40	0.31	0.60	0.34
[FA hydroxy(17:2)] 7-hydroxy-10E_16-heptadecadien-8-ynoic acid	ME417099	0.27	3.50	1.11	0.39
TG 4:0/4:0/4:0	ME417423	0.27	3.58	1.35	0.22
CAR 14:1	ME417211	0.13	3.38	1.56	0.28
CAR 16:1;OH	ME417215	0.18	3.63	1.60	0.12
[FA methyl(18:2)] methyl 9_10-epoxy-12_15-octadecadienoate	ME417072	0.13	3.59	1.74	0.09
Khellol glucoside	ME416983	0.59	3.01	0.75	0.57
Iridotrial	ME417255	0.22	2.87	1.57	0.20
Burseran	ME417206	0.42	2.90	1.37	0.38
Deoxygomisin A	ME416960	0.36	2.97	1.36	0.41
MG(P-18:0e/0:0/0:0)	ME417111	0.43	2.99	1.33	0.36
(25S)-5alpha-cholestan-3beta_6alpha_7beta_8beta_15alpha_16beta_26-heptol	ME417146	0.48	2.72	1.36	0.43
3_5-Di-O-methyl-8-prenylafzelechin-4beta-ol	ME417123	0.46	2.84	1.27	0.45
12-OPDA	ME417044	0.43	3.22	1.22	0.33
Stigmatellin Y	ME417419	0.56	3.05	1.33	0.25
Pleuromutilin	ME417370	NA	1.25	0.81	NA
3_7-Dimethyl-2E_6E-decadien-1_10-dioic acid	ME417083	NA	1.51	0.62	NA
Coniferyl alcohol	ME417226	NA	1.50	0.76	0.23
Rubraflavone D	ME417124	0.46	2.09	1.68	0.53
Linoleamide	ME417259	0.56	2.09	1.48	0.57
Oleamide	ME417311	0.47	2.04	1.55	0.62
DG 36:2	ME417234	0.58	1.72	1.26	0.85
1_2-dioctanoyl-1_2_6-hexanetriol	ME416950	0.73	1.69	1.55	0.58
N_N-dimethyl-9S_11R_15S-trihydroxy-5Z_13E-prostadien-1-amide	ME417086	0.76	1.86	1.24	0.63
3_7_11_15-Tetramethyl-6_10_14-hexadecatrien-1-ol	ME417011	0.58	1.74	1.41	0.75
FA methyl(16:1)	ME417051	0.69	1.78	1.41	0.65
Pentadecanal	ME417355	0.60	1.86	1.50	0.63
5-O-Methylembelin	ME417190	0.59	1.95	1.36	0.68
2-Methoxyhexadecanoic acid	ME417184	0.69	1.97	1.41	0.57
N-Oleoyl threonine	ME417304	0.63	1.96	1.52	0.55
Auricularine	ME417200	0.77	2.13	1.12	0.61
Precocene 2	ME416955	0.68	2.08	1.10	0.71
ML 236C	ME417301	0.63	2.16	1.12	0.70
Phenylpyruvic acid	ME417361	0.65	2.13	1.14	0.69
ubiquinol-1	ME416956	0.66	2.12	1.11	0.70
4-Heptyloxybenzoic acid	ME416959	0.42	2.34	1.01	0.42
5_6_7_8-Tetrahydro-2-naphthol	ME416943	0.65	2.18	0.99	0.42
Leupeptin	ME417257	0.43	2.54	1.51	0.45
[PR] Tretinoin/All-Trans Retinoic Acid	ME417126	0.33	2.32	1.28	0.75
Militarinone A	ME417300	0.53	2.60	1.24	0.51
Cinegalline	ME416976	0.56	2.48	1.19	0.57
Magnoshinin	ME417286	0.53	2.37	1.20	0.64
N-Oleoyl glycine	ME417303	0.25	2.57	2.18	0.19
Apoatropine	ME417198	0.44	2.30	1.91	0.32
Isococculidine	ME416991	0.51	2.16	1.83	0.38
C17 Sphingosine	ME417207	0.58	1.82	2.03	0.36
Pristanal	ME417372	0.41	2.07	2.17	0.30
Palmitamide	ME417318	0.50	1.11	0.87	1.39
PI 42:6	ME417369	NA	0.95	0.98	1.15
17alpha-Hydroxypregnenolone	ME417182	0.71	1.26	1.60	0.75
FA amino(18:0)	ME417094	0.61	1.29	1.71	0.75
(9S_10S)-9_10-Dihydroxyoctadecanoate	ME416982	0.81	1.23	1.42	0.80
myristic amide	ME416973	0.65	1.40	1.38	0.86
[FA hydroxy(18:0)] 9_10-dihydroxy-octadecanoic acid	ME417091	0.79	1.43	1.41	0.73
[FA methyl(16:1)] 14-methyl-8-hexadecen-1-ol	ME417096	0.73	1.55	1.32	0.78
Palmitoleamide	ME417319	0.67	1.52	1.38	0.79
2_6_8_12-Tetramethyl-2_4-tridecadien-1-ol	ME417017	0.98	1.26	1.22	0.69
1_2-dioctanoyl-3-methyl-1_2_3-butanetriol	ME416966	0.80	1.43	0.96	0.98
MG 14:0	ME417293	0.80	1.51	1.02	0.92
6Z_9Z-Nonadecadien-3-one	ME417013	0.95	1.41	1.07	0.82
FA hydroxy(19:0)] nonadecanoic acid	ME417008	0.84	1.31	1.22	0.86
3_ 5-Tetradecadiencarnitine	ME416979	0.81	1.35	1.19	0.88
Tremetone	ME417426	0.78	1.37	1.17	0.90
Dodecanamide	ME417245	0.78	1.45	1.24	0.83
2_3-Dihydroxycyclopentaneundecanoic acid	ME416962	0.79	1.42	1.17	0.87
Dodecenoic acid	ME417246	0.82	1.45	1.13	0.86
PC 44:11	ME417339	1.11	1.54	0.58	0.93
PS 40:3	ME417382	1.05	1.50	0.77	0.85
3-Hydroxy-11Z-octadecenoylcarnitine	ME416986	0.92	1.20	0.54	1.23
1-Dodecanoyl-sn-glycerol	ME417105	1.10	1.16	0.48	1.16
FA oxo(15:0)	ME417040	1.10	1.19	0.50	1.13
CAR 16:1	ME417214	0.92	1.21	0.81	1.08
Barringtogenol C	ME416987	0.95	1.36	0.73	1.03
Calcimycin	ME417208	0.94	1.40	0.63	1.10
CAR 18:1	ME417218	0.98	1.32	0.59	1.11
3-Methoxy-5_10-seco-5_19-cycloandrosta-1(10)_2_4-trien-17-one	ME416963	0.38	1.92	0.53	1.31
PS 40:2	ME417381	0.84	2.18	0.52	0.88
PS 38:1	ME417379	0.71	1.67	0.74	0.97
cis-Vaccenic acid	ME417225	0.85	1.82	0.67	0.95
Phytosphingosine	ME417362	0.88	1.84	0.68	0.91

Factors:

F1	Treatment:cele_HFD
F2	Treatment:Cele_pro
F3	Treatment:CFD
F4	Treatment:HFD

Data matrix